A case of anaphylaxis to alemtuzumab

J Neurol. 2019 Mar;266(3):780-781. doi: 10.1007/s00415-019-09214-2. Epub 2019 Feb 4.

Authors

Charles J S Nye¹, Annette Wagner², Onajite Kousin-Ezewu³, Joanne L Jones³, Alasdair J Coles³

Affiliations

¹ University of Cambridge, Cambridge, UK. charles.nye@nhs.net.
² Department of Allergy and Immunology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
³ Department of Clinical Neurosciences, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

PMID: 30715557
DOI: 10.1007/s00415-019-09214-2

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Alemtuzumab / adverse effects*
Anaphylaxis / chemically induced*
Female
Humans
Immunologic Factors / adverse effects*
Multiple Sclerosis, Relapsing-Remitting / drug therapy*
Young Adult

Substances

Immunologic Factors
Alemtuzumab